PAR HEALTH
LIVE

Serial Number

99169735

Owner

PH HEALTH LIMITED

Attorney

Camille M. Miller

Filing Date

May 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PAR HEALTH Trademark

Serial Number: 99169735

PAR HEALTH is a trademark filed by PH HEALTH LIMITED on May 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

PH HEALTH LIMITED (73 trademarks)

FIRST FLOOR MINERVA HOUSE
BALLSBRIDGE, DUBLIN 4 D04 H9P8 , IE

Entity Type: 99

Endo Operations Limited

First Floor, Minerva House
Ballsbridge Dublin 4 , IE

Entity Type: 99

Trademark Details

Filing Date

May 5, 2025

Registration Date

Not Registered

Published for Opposition

November 18, 2025

Goods & Services

Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; Pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Aug 11, 2026 SUPC
USE AMENDMENT FILED
Jun 26, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 26, 2026 EISU
SOU TEAS EXTENSION RECEIVED
Jun 12, 2026 EEXT
TEAS STATEMENT OF USE RECEIVED
Apr 16, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Apr 16, 2026 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 13, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2025 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 14, 2025 ASGN
APPLICATION FILING RECEIPT MAILED
May 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2025 NWOS
NEW APPLICATION ENTERED
May 5, 2025 NWAP